Pharmacokinetics of Human Leukocyte Interferon

Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectable in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramus...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1976-06, Vol.133 (Supplement-2), p.A6-A12
Main Authors: Cantell, K., Pyhälä, Liisa
Format: Article
Language:English
Subjects:
Animals
Blood
Blood plasma
Dosage
Female
Humans
Injections, Intramuscular
Injections, Intravenous
Injections, Subcutaneous
Interferon: Properties and Production
Interferons
Interferons - analysis
Interferons - blood
Intravenous injections
Kinetics
Leukocytes
Lymph
Lymph - analysis
Male
Pharmacokinetics
Pregnancy
Rabbits
Rats
Rats, Inbred Strains
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c373t-c0fd2a22b6f6adb6ed3c47a0196366393e9a951f6088940b4d01482fefea3e073
cites
container_end_page A12
container_issue Supplement-2
container_start_page A6
container_title The Journal of infectious diseases
container_volume 133
creator Cantell, K.
Pyhälä, Liisa
description Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectable in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramuscular injections had no effect on the kinetics of circulating interferon. The purity of the preparation influenced the rate at which interferon entered the blood after intramuscular or subcutaneous injection but did not affect clearance from the blood after intravenous injection. The circulating interferons obtained after intravenous or intramuscular administration cleared at similar rates. During the first 1–2 hr after intravenous or intramuscular injection into rats, the interferon levels were lower in lymph than in serum; after 2 hr lymph and serum samples contained similar amounts of interferon.
doi_str_mv 10.1093/infdis/133.Supplement_2.A6
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_83408321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30107927</jstor_id><sourcerecordid>30107927</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-c0fd2a22b6f6adb6ed3c47a0196366393e9a951f6088940b4d01482fefea3e073</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoP4Vav_QKF48LbtJLNNNt5KsVaoKKgoXkK6O8G13Q-TXbD_3spK8TSH531nhoexSw5DDhpHeemyPIw44vCpres1FVQ2Rgwnco_1-BhVJCXHfdYDECLiidbH7CSETwCIUaojdqhRjEH22PDxw_rCptUqL6nJ0zCo3GDeFrYcLKhdVemmocFd2ZB35KvylB04uw509jf77GV28zydR4uH27vpZBGlqLCJUnCZsEIspZM2W0rKMI2VBa4lSokaSVs95k5CkugYlnEGPE6EI0cWCRT22VW3t_bVV0uhMUUeUlqvbUlVG0yCMSQo-DZ43QVTX4XgyZna54X1G8PB_LoynSuzdWX-uzITuS2f_11plwVlu2onZ4svOvwZmsrvKAIHpcXvk1HH89DQ945bvzJSoRqb-du7Af6q7nE2M4g_cxSDbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83408321</pqid></control><display><type>article</type><title>Pharmacokinetics of Human Leukocyte Interferon</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>Oxford University Press Archive</source><creator>Cantell, K. ; Pyhälä, Liisa</creator><creatorcontrib>Cantell, K. ; Pyhälä, Liisa</creatorcontrib><description>Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectable in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramuscular injections had no effect on the kinetics of circulating interferon. The purity of the preparation influenced the rate at which interferon entered the blood after intramuscular or subcutaneous injection but did not affect clearance from the blood after intravenous injection. The circulating interferons obtained after intravenous or intramuscular administration cleared at similar rates. During the first 1–2 hr after intravenous or intramuscular injection into rats, the interferon levels were lower in lymph than in serum; after 2 hr lymph and serum samples contained similar amounts of interferon.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/133.Supplement_2.A6</identifier><identifier>PMID: 932506</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Animals ; Blood ; Blood plasma ; Dosage ; Female ; Humans ; Injections, Intramuscular ; Injections, Intravenous ; Injections, Subcutaneous ; Interferon: Properties and Production ; Interferons ; Interferons - analysis ; Interferons - blood ; Intravenous injections ; Kinetics ; Leukocytes ; Lymph ; Lymph - analysis ; Male ; Pharmacokinetics ; Pregnancy ; Rabbits ; Rats ; Rats, Inbred Strains</subject><ispartof>The Journal of infectious diseases, 1976-06, Vol.133 (Supplement-2), p.A6-A12</ispartof><rights>Copyright 1976 University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-c0fd2a22b6f6adb6ed3c47a0196366393e9a951f6088940b4d01482fefea3e073</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30107927$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30107927$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,58236,58469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/932506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cantell, K.</creatorcontrib><creatorcontrib>Pyhälä, Liisa</creatorcontrib><title>Pharmacokinetics of Human Leukocyte Interferon</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectable in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramuscular injections had no effect on the kinetics of circulating interferon. The purity of the preparation influenced the rate at which interferon entered the blood after intramuscular or subcutaneous injection but did not affect clearance from the blood after intravenous injection. The circulating interferons obtained after intravenous or intramuscular administration cleared at similar rates. During the first 1–2 hr after intravenous or intramuscular injection into rats, the interferon levels were lower in lymph than in serum; after 2 hr lymph and serum samples contained similar amounts of interferon.</description><subject>Animals</subject><subject>Blood</subject><subject>Blood plasma</subject><subject>Dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Injections, Intravenous</subject><subject>Injections, Subcutaneous</subject><subject>Interferon: Properties and Production</subject><subject>Interferons</subject><subject>Interferons - analysis</subject><subject>Interferons - blood</subject><subject>Intravenous injections</subject><subject>Kinetics</subject><subject>Leukocytes</subject><subject>Lymph</subject><subject>Lymph - analysis</subject><subject>Male</subject><subject>Pharmacokinetics</subject><subject>Pregnancy</subject><subject>Rabbits</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><recordid>eNpNkE1LAzEQhoP4Vav_QKF48LbtJLNNNt5KsVaoKKgoXkK6O8G13Q-TXbD_3spK8TSH531nhoexSw5DDhpHeemyPIw44vCpres1FVQ2Rgwnco_1-BhVJCXHfdYDECLiidbH7CSETwCIUaojdqhRjEH22PDxw_rCptUqL6nJ0zCo3GDeFrYcLKhdVemmocFd2ZB35KvylB04uw509jf77GV28zydR4uH27vpZBGlqLCJUnCZsEIspZM2W0rKMI2VBa4lSokaSVs95k5CkugYlnEGPE6EI0cWCRT22VW3t_bVV0uhMUUeUlqvbUlVG0yCMSQo-DZ43QVTX4XgyZna54X1G8PB_LoynSuzdWX-uzITuS2f_11plwVlu2onZ4svOvwZmsrvKAIHpcXvk1HH89DQ945bvzJSoRqb-du7Af6q7nE2M4g_cxSDbA</recordid><startdate>197606</startdate><enddate>197606</enddate><creator>Cantell, K.</creator><creator>Pyhälä, Liisa</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197606</creationdate><title>Pharmacokinetics of Human Leukocyte Interferon</title><author>Cantell, K. ; Pyhälä, Liisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-c0fd2a22b6f6adb6ed3c47a0196366393e9a951f6088940b4d01482fefea3e073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Animals</topic><topic>Blood</topic><topic>Blood plasma</topic><topic>Dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Injections, Intravenous</topic><topic>Injections, Subcutaneous</topic><topic>Interferon: Properties and Production</topic><topic>Interferons</topic><topic>Interferons - analysis</topic><topic>Interferons - blood</topic><topic>Intravenous injections</topic><topic>Kinetics</topic><topic>Leukocytes</topic><topic>Lymph</topic><topic>Lymph - analysis</topic><topic>Male</topic><topic>Pharmacokinetics</topic><topic>Pregnancy</topic><topic>Rabbits</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cantell, K.</creatorcontrib><creatorcontrib>Pyhälä, Liisa</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cantell, K.</au><au>Pyhälä, Liisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of Human Leukocyte Interferon</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1976-06</date><risdate>1976</risdate><volume>133</volume><issue>Supplement-2</issue><spage>A6</spage><epage>A12</epage><pages>A6-A12</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectable in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramuscular injections had no effect on the kinetics of circulating interferon. The purity of the preparation influenced the rate at which interferon entered the blood after intramuscular or subcutaneous injection but did not affect clearance from the blood after intravenous injection. The circulating interferons obtained after intravenous or intramuscular administration cleared at similar rates. During the first 1–2 hr after intravenous or intramuscular injection into rats, the interferon levels were lower in lymph than in serum; after 2 hr lymph and serum samples contained similar amounts of interferon.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>932506</pmid><doi>10.1093/infdis/133.Supplement_2.A6</doi></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1976-06, Vol.133 (Supplement-2), p.A6-A12
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_83408321
source JSTOR Archival Journals and Primary Sources Collection【Remote access available】; Oxford University Press Archive
subjects Animals
Blood
Blood plasma
Dosage
Female
Humans
Injections, Intramuscular
Injections, Intravenous
Injections, Subcutaneous
Interferon: Properties and Production
Interferons
Interferons - analysis
Interferons - blood
Intravenous injections
Kinetics
Leukocytes
Lymph
Lymph - analysis
Male
Pharmacokinetics
Pregnancy
Rabbits
Rats
Rats, Inbred Strains
title Pharmacokinetics of Human Leukocyte Interferon
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20Human%20Leukocyte%20Interferon&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Cantell,%20K.&rft.date=1976-06&rft.volume=133&rft.issue=Supplement-2&rft.spage=A6&rft.epage=A12&rft.pages=A6-A12&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/133.Supplement_2.A6&rft_dat=%3Cjstor_proqu%3E30107927%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c373t-c0fd2a22b6f6adb6ed3c47a0196366393e9a951f6088940b4d01482fefea3e073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=83408321&rft_id=info:pmid/932506&rft_jstor_id=30107927&rfr_iscdi=true